Julio Arrizabalaga

Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy

Juan Berenguer, Pilar Miralles, Julio Arrizabalaga et al. · Clinical Infectious Diseases · 2003 · 136 citations · Full text

Prognosis and Clinical Evaluation of Infection Caused by Rhodococcus equi in HIV-Infected Patientsa

M. Torres-Tortosa, Julio Arrizabalaga, Joseé L. Villanueva et al. · CHEST Journal · 2003 · 101 citations

Clinical Infection, Hiv-infected Patientsa, Hiv +4

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron et al. · The Lancet HIV · 2020 · 68 citations · Full text

Primary Immunodeficiency, Treatment And Prevention, Human Retrovirus +9

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study

Felipe García, Joan Romeu, Inmaculada Grau et al. · AIDS · 1999 · 54 citations

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy

José L. Casado, Julio Arrizabalaga, P Martí-Belda et al. · AIDS · 1999 · 54 citations